A long-acting HIV drug arrives in Zimbabwe for some at highest risk
Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year
Boston 25 Now
Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year
/cloudfront-us-east-1.images.arcpublishing.com/cmg/7QOJU3BNCJERBNKJC5LWTBYFLU.png)
